EORTC Cancer Research Evaluation Committee
GPTKB entity
Statements (46)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Committee
|
gptkbp:aims_to |
improve cancer treatment
enhance research quality |
gptkbp:collaborates_with |
clinical researchers
|
gptkbp:contributes_to |
patient care
|
gptkbp:develops |
gptkb:guidelines
|
gptkbp:engages_in |
educational activities
|
gptkbp:established_in |
gptkb:1962
|
gptkbp:evaluates |
treatment protocols
|
gptkbp:facilitates |
data sharing
|
gptkbp:focuses_on |
cancer research
|
gptkbp:has_goal |
improving patient outcomes
promoting innovation conducting research developing new therapies enhancing education fostering collaboration advancing cancer research increasing awareness supporting clinical trials |
gptkbp:has_members |
nurses
statisticians oncologists research scientists clinical trial coordinators |
https://www.w3.org/2000/01/rdf-schema#label |
EORTC Cancer Research Evaluation Committee
|
gptkbp:is_involved_in |
data analysis
patient recruitment safety monitoring protocol development regulatory submissions outcome assessment |
gptkbp:is_supported_by |
grants
donations sponsorships |
gptkbp:location |
gptkb:Brussels,_Belgium
|
gptkbp:organizes |
conferences
|
gptkbp:part_of |
gptkb:EORTC
|
gptkbp:provides |
clinical trial support
expertise in oncology |
gptkbp:publishes |
research findings
|
gptkbp:reviews |
cancer studies
|
gptkbp:supports |
multinational trials
|
gptkbp:works_with |
pharmaceutical companies
|
gptkbp:bfsParent |
gptkb:European_Organisation_for_Research_and_Treatment_of_Cancer
|
gptkbp:bfsLayer |
8
|